Recent Articles

USPTO News: Online Priority Document Exchange Service Between USPTO and KIPO

Kevin E. Noonan
October 10, 2008 05:01

By Christopher P. Singer -- We have learned from one of our foreign associates that the Korean Intellectual Property Office (KIPO) announced that it will launch an online priority document exchange (PDX) service with the U.S. Patent and Trademark Office (USPTO) beginning on October 14, 2008. The...

Victory for Amgen in District Court Decision - Part III

Kevin E. Noonan
October 10, 2008 04:55

By Kevin E. Noonan -- As Patent Docs has reported (see Part I and Part II), last week District Court Judge William G. Young (D. Mass) issued a 150-page decision on post-trial motions and a permanent injunction, and provided his rationale for a number of pretrial summary judgment motion decisions,...

USPTO News: USPTO Performance Review Board Members Announced

Kevin E. Noonan
October 10, 2008 04:44

By Christopher P. Singer -- In a Notice published in the Federal Register on October 9, 2008, the U.S. Patent and Trademark Office announced the names of persons that have been appointed to the Performance Review Board. Among the twelve familiar names constituting the Board, Margaret J. A. Peterlin...

Victory for Amgen in District Court Decision - Part II

Kevin E. Noonan
October 10, 2008 04:38

By Kevin E. Noonan -- On October 2nd, District Court Judge William G. Young (D. Mass) issued a decision on post-trial motions and a permanent injunction in Amgen Inc. v. Hoffmann-LaRoche, Amgen's patent infringement suit over Roche's Mircera® drug product. In a 150-page opinion, Judge Young handed ...

Victory for Amgen in District Court Decision - Part I

Kevin E. Noonan
October 10, 2008 04:33

By Kevin E. Noonan -- On October 2nd, District Court Judge William G. Young (D. Mass) issued a decision on post-trial motions and a permanent injunction in Amgen Inc. v. Hoffmann-LaRoche, Amgen's patent infringement suit over Roche's Mircera® drug product. In a 150-page opinion, Judge Young handed ...

Unhappy with the Ex parte Appeal Rule? Read This Now -- Updated

Kevin E. Noonan
October 09, 2008 15:28

By Richard Belzer -- The U.S. Patent and Trademark Office (PTO) today published a notice in the Federal Register inviting public comments on paperwork burdens associated with the changes in the procedural requirements for ex parte appeals (73 Fed. Reg. 32937-32977, June 10, 2008). This notice...

Impax Laboratories, Inc. v. Aventis Pharmaceuticals Inc. (Fed. Cir. 2008)

Kevin E. Noonan
October 08, 2008 05:00

By Donald Zuhn -- Last Friday, the Federal Circuit affirmed the determination by the District Court for the District of Delaware that U.S. Patent No. 5,236,940 does not qualify as an enabling prior art reference, and therefore, does not anticipate claims 1-5 of U.S. Patent No. 5,527,814. The '814...

Court Report

Kevin E. Noonan
October 06, 2008 03:39

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Proctor & Gamble Co. et al. v. Teva Pharmaceuticals USA Inc.1:08-cv-00627; filed September 26, 2009 in the...

Court Report

Kevin E. Noonan
October 06, 2008 03:31

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Sepracor Inc. and University of Massachusetts v. Pharmaceutical Associates, Inc.3:08-cv-04718; filed September...

Conference & CLE Calendar

Kevin E. Noonan
October 06, 2008 03:30

October 6-7, 2008 - Patent Litigation 2008 (Practising Law Institute) - McLean, VA October 7-8, 2008 - Global Patent Litigation*** (American Conference Institute) - New York, NY October 15, 2008 - Developments in Pharmaceutical and Biotech Patent Law (Practising Law Institute) - San Francisco, CA...